A study published in the November issue of Redox Biology has found that adding intravenous, high-dose vitamin C to a chemotherapy regimen doubled the survival of patients with late-stage ...

Sleeping well, eating clean and working out are essential to live a long and healthy life. But people often pick up ...

A randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic pancreatic cancer ...

Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic ...

Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in pancreatic cancer patients. Study author Dr. Cullen and oncologists discuss.

The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic cancer, according to results of a randomized phase 2 trial.Vitamin C also ...

The disruption of gut bacteria from high-dose vitamin C affects your microbiome balance and can contribute to digestive problems that persist even after discontinuing supplements.

A University of Iowa Health Care randomized, phase 2 clinical trial shows that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage ...

High doses of vitamin C, when combined with standard chemotherapy, may significantly extend the life expectancy of patients with advanced pancreatic cancer.

They are available in a variety of forms, including tablets, gummies, and liquids. Vitamin C is usually well tolerated, although high doses can cause diarrhea, nausea, and stomach cramps.

Medical researchers with the University of Iowa published a study last month which found that high doses of vitamin C, administered through an IV, increased the life-span of individuals diagnosed ...

High doses of vitamin C could be a new breakthrough in treating cancer. The University of Iowa Health Care Carver College of Medicine has shared results from a randomized, phase 2 trial testing ...